270 related articles for article (PubMed ID: 27900607)
1. Mammalian Nucleotidyl Cyclases and Their Nucleotide Binding Sites.
Dove S
Handb Exp Pharmacol; 2017; 238():49-66. PubMed ID: 27900607
[TBL] [Abstract][Full Text] [Related]
2. Structure/activity relationships of (M)ANT- and TNP-nucleotides for inhibition of rat soluble guanylyl cyclase α1β1.
Dove S; Danker KY; Stasch JP; Kaever V; Seifert R
Mol Pharmacol; 2014 Apr; 85(4):598-607. PubMed ID: 24470063
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of human soluble adenylyl cyclase and crystal structures of its nucleotide complexes-implications for cyclase catalysis and evolution.
Kleinboelting S; van den Heuvel J; Steegborn C
FEBS J; 2014 Sep; 281(18):4151-64. PubMed ID: 25040695
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides.
Gille A; Lushington GH; Mou TC; Doughty MB; Johnson RA; Seifert R
J Biol Chem; 2004 May; 279(19):19955-69. PubMed ID: 14981084
[TBL] [Abstract][Full Text] [Related]
5. Substrate specificity determinants of class III nucleotidyl cyclases.
Bharambe NG; Barathy DV; Syed W; Visweswariah SS; Colaςo M; Misquith S; Suguna K
FEBS J; 2016 Oct; 283(20):3723-3738. PubMed ID: 27542992
[TBL] [Abstract][Full Text] [Related]
6. Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1.
Beste KY; Burhenne H; Kaever V; Stasch JP; Seifert R
Biochemistry; 2012 Jan; 51(1):194-204. PubMed ID: 22122229
[TBL] [Abstract][Full Text] [Related]
7. Cyclic Nucleotide Monophosphates in Plants and Plant Signaling.
Marondedze C; Wong A; Thomas L; Irving H; Gehring C
Handb Exp Pharmacol; 2017; 238():87-103. PubMed ID: 26721677
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of various adenylyl cyclase isoforms and soluble guanylyl cyclase by 2',3'-O-(2,4,6-trinitrophenyl)-substituted nucleoside 5'-triphosphates.
Suryanarayana S; Göttle M; Hübner M; Gille A; Mou TC; Sprang SR; Richter M; Seifert R
J Pharmacol Exp Ther; 2009 Sep; 330(3):687-95. PubMed ID: 19494187
[TBL] [Abstract][Full Text] [Related]
9. Broad specificity of mammalian adenylyl cyclase for interaction with 2',3'-substituted purine- and pyrimidine nucleotide inhibitors.
Mou TC; Gille A; Suryanarayana S; Richter M; Seifert R; Sprang SR
Mol Pharmacol; 2006 Sep; 70(3):878-86. PubMed ID: 16766715
[TBL] [Abstract][Full Text] [Related]
10. Catalytic mechanism of the adenylyl and guanylyl cyclases: modeling and mutational analysis.
Liu Y; Ruoho AE; Rao VD; Hurley JH
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13414-9. PubMed ID: 9391039
[TBL] [Abstract][Full Text] [Related]
11. A guanylyl cyclase from Paramecium with 22 transmembrane spans. Expression of the catalytic domains and formation of chimeras with the catalytic domains of mammalian adenylyl cyclases.
Linder JU; Hoffmann T; Kurz U; Schultz JE
J Biol Chem; 2000 Apr; 275(15):11235-40. PubMed ID: 10753932
[TBL] [Abstract][Full Text] [Related]
12. Nucleotidyl cyclase activity of particulate guanylyl cyclase A: comparison with particulate guanylyl cyclases E and F, soluble guanylyl cyclase and bacterial adenylyl cyclases CyaA and edema factor.
Beste KY; Spangler CM; Burhenne H; Koch KW; Shen Y; Tang WJ; Kaever V; Seifert R
PLoS One; 2013; 8(7):e70223. PubMed ID: 23922959
[TBL] [Abstract][Full Text] [Related]
13. Structures, mechanism, regulation and evolution of class III nucleotidyl cyclases.
Sinha SC; Sprang SR
Rev Physiol Biochem Pharmacol; 2006; 157():105-40. PubMed ID: 17236651
[TBL] [Abstract][Full Text] [Related]
14. Structure, mechanism, and regulation of soluble adenylyl cyclases - similarities and differences to transmembrane adenylyl cyclases.
Steegborn C
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt B):2535-47. PubMed ID: 25193033
[TBL] [Abstract][Full Text] [Related]
15. cCMP and cUMP Across the Tree of Life: From cCMP and cUMP Generators to cCMP- and cUMP-Regulated Cell Functions.
Seifert R
Handb Exp Pharmacol; 2017; 238():3-23. PubMed ID: 28181008
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate.
Mou TC; Gille A; Fancy DA; Seifert R; Sprang SR
J Biol Chem; 2005 Feb; 280(8):7253-61. PubMed ID: 15591060
[TBL] [Abstract][Full Text] [Related]
17. Synergistic mutations in soluble guanylyl cyclase (sGC) reveal a key role for interfacial regions in the sGC activation mechanism.
Childers KC; Yao XQ; Giannakoulias S; Amason J; Hamelberg D; Garcin ED
J Biol Chem; 2019 Nov; 294(48):18451-18464. PubMed ID: 31645439
[TBL] [Abstract][Full Text] [Related]
18. Rhodopsin-cyclases for photocontrol of cGMP/cAMP and 2.3 Å structure of the adenylyl cyclase domain.
Scheib U; Broser M; Constantin OM; Yang S; Gao S; Mukherjee S; Stehfest K; Nagel G; Gee CE; Hegemann P
Nat Commun; 2018 May; 9(1):2046. PubMed ID: 29799525
[TBL] [Abstract][Full Text] [Related]
19. Exchange of substrate and inhibitor specificities between adenylyl and guanylyl cyclases.
Sunahara RK; Beuve A; Tesmer JJ; Sprang SR; Garbers DL; Gilman AG
J Biol Chem; 1998 Jun; 273(26):16332-8. PubMed ID: 9632695
[TBL] [Abstract][Full Text] [Related]
20. Conversion of a guanylyl cyclase to an adenylyl cyclase.
Beuve A
Methods; 1999 Dec; 19(4):545-50. PubMed ID: 10581153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
